Chembio Diagnostics, Inc.

    Jurisdiction
    United States
    ISIN
    US1635722093 (CEMI)
    Sectors
    1. Healthcare
    2. Medical - Diagnostics & Research

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    5 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    6 / 7

    Profile

    Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €41.65M
    Gross margin
    20.2%
    EBIT
    -€20.37M
    EBIT margin
    -48.9%
    Net income
    -€20.07M
    Net margin
    -48.2%

    Statement period: - (published )

    Dividends

    No dividend payouts

    Products

    Product Revenue
    License And Royalty Revenue €1.14M 2.7%
    Research And Development Revenue €112.99K 0.3%

    Earnings Calls

    Latest earnings call: November 6, 2022

    Add to watchlist

    Notifications